Stem Cells and their Key Derivatives in Degenerative Musculoskeletal Diseases
Stem Cell Reviews and Reports · 2026
DOI: 10.1007/s12015-026-11080-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, 2026. Verfasst von Nawaz Khan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Guangdong Artificial Intelligence Biomedical Innovation Platform, Shenzhen Second People's Hospital, Shenzhen Second Peopl…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Musculoskeletal Diseases, Intervertebral Disc Degeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 224 Literaturangaben. Gefördert von: Shenzhen Medical Research Fund, Natural Science Foundation of Guangdong Province, Shenzhen Science and Technology Projects.
Abstract (Originalsprache)
Degenerative musculoskeletal diseases such as osteoporosis (OP), osteoarthritis (OA), and intervertebral disc degeneration (IVDD) represent a growing global health challenge, causing disability, pain, and socioeconomic burden. Traditional therapies remain largely palliative, underscoring the urgent need for regenerative approaches. Mesenchymal stem cells (MSCs) are promising tools due to their capacity for multilineage differentiation, immunomodulation, and paracrine signaling. However, challenges including heterogeneity, low engraftment, and manufacturing complexity limit their clinical translation. Increasingly, extracellular vesicles (EVs) derived from MSCs have been recognized as the principal mediators of their therapeutic effects. MSC-derived-EVs (MSC-EVs) provide a safer, cell-free platform capable of regulating immune responses, promoting tissue regeneration, and delivering bioactive cargos that restore bone, cartilage, and disc homeostasis. Preclinical and early clinical data highlight their potential as next-generation therapeutics. The aim of this review is to provide valuable insights into the development and evaluation of MSCs and MSC-EVs in OA, OP, and IVDD thereby accelerating clinical translation and improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, Guangdong Artificial Intelligence Biomedical Innovation Platform, Shenzhen Second People's Hospital, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Sh…
- Medical Innovation Technology Transformation Center of Shenzhen Second People Hospital the First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, Guangdong, China.
- Medical School, Shenzhen University, Shenzhen, 518060, Guangdong, China.
- Department of Child and Adolescent Psychiatry, Shenzhen Kangning Hospital, Shenzhen Institute of Mental Health, Shenzhen, Guangdong, China.
- Medical Innovation Technology Transformation Center of Shenzhen Second People Hospital the First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, Guangdong, China. duanl@szu.edu.cn.
Förderung
- Shenzhen Medical Research Fund
- Natural Science Foundation of Guangdong Province
- Shenzhen Science and Technology Projects
- Medical-Engineering Interdisciplinary Research Foundation of Shenzhen University
Zitieren
APA
Khan, N., Ahmadova, Z., Zeng, B., Ahmed, W., Shafiq, T., Zhang, Z., Su, A., Muhammad, N., Khan, S., Liang, Y., & Duan, L. (2026). Stem Cells and their Key Derivatives in Degenerative Musculoskeletal Diseases. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-026-11080-1
Vancouver
Khan N, Ahmadova Z, Zeng B, Ahmed W, Shafiq T, Zhang Z, et al. Stem Cells and their Key Derivatives in Degenerative Musculoskeletal Diseases. Stem Cell Reviews and Reports. 2026. doi:10.1007/s12015-026-11080-1
BibTeX
@article{Khan2026,
author = {Khan, Nawaz and Ahmadova, Zeynab and Zeng, Bin and Ahmed, Waqas and Shafiq, Tayyab and Zhang, Zihao and Su, Aiyuan and Muhammad, Nazim and Khan, Sajid and Liang, Yujie and Duan, Li},
title = {Stem Cells and their Key Derivatives in Degenerative Musculoskeletal Diseases},
journal = {Stem Cell Reviews and Reports},
year = {2026},
doi = {10.1007/s12015-026-11080-1}
}
EUVIMED